TG Therapeutics, Inc. is a biopharmaceutical company focusing on innovative treatments for B-cell mediated diseases. Their products include BRIUMVI for multiple sclerosis and Umbralisib for lymphoma. The company also has various investigational medicines in its research pipeline.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing